original ) (raw )Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
Garth Ringheim
Annals of the rheumatic diseases, 2018
View PDFchevron_right
Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity
Garth Ringheim
The Journal of Immunology
View PDFchevron_right
Meant to B: B cells as a therapeutic target in systemic lupus erythematosus
betty diamond
Journal of Clinical Investigation, 2021
View PDFchevron_right
Increased Expression of B Cell Activation Factor Supports the Abnormal Expansion of Transitional B Cells in Systemic Lupus Erythematosus
Paul Fortin
The Journal of Rheumatology, 2011
View PDFchevron_right
Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
Wayel Abdulahad
Lupus, 2009
View PDFchevron_right
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus
Paul Hertzog
Arthritis Research & Therapy, 2009
View PDFchevron_right
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling
Edward A Clark
Arthritis Research & Therapy, 2017
View PDFchevron_right
B-cell Biology and Related Therapies in Systemic Lupus Erythematosus
Sadia Ahmed
Rheumatic Disease Clinics of North America, 2010
View PDFchevron_right
The Role of B Cells in Autoimmunity: Insights on B Lymphocyte Stimulation (Blys) as a Target for Biologics in Systemic Lupus Erythematosus
Mark Aragones
Journal of Clinical & Cellular Immunology, 2015
View PDFchevron_right
B lymphocytes and systemic lupus erythematosus
Lisa Criscione , David Pisetsky
Current Rheumatology Reports, 2003
View PDFchevron_right
B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases
William Stohl
Current Rheumatology Reports, 2002
View PDFchevron_right
Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus
Christophe Jamin , P. Youinou , Pierre Youinou
Immunology, 2007
View PDFchevron_right
Expression Profile of Fc RIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus
Andrew Gibson
The Journal of Immunology, 2007
View PDFchevron_right
Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus
Jun Zhang
The Journal of Immunology, 2001
View PDFchevron_right
Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus
Eduardo Vazquez
Arthritis and Rheumatism, 2002
View PDFchevron_right
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus
Andrea Sanchis Gregorio
Arthritis & Rheumatism, 2010
View PDFchevron_right
Repertoire analysis of anergic B cells from patients with systemic lupus erythematosus
Nancy Longo
Arthritis Research & Therapy - ARTHRITIS RES THER, 2003
View PDFchevron_right
B Cell Modulation Strategies in Autoimmunity: The SLE Example
Maria Rosado
Current Pharmaceutical Design, 2011
View PDFchevron_right
B-Cell Targeted Therapies in Systemic Lupus Erythematosus
Helen Tsang
BioDrugs, 2013
View PDFchevron_right
B cells in SLE: Different biological drugs for different pathogenic mechanisms
Rita Carsetti
Autoimmunity Reviews, 2007
View PDFchevron_right
Circulating anergic B cells in the periphery of active systemic lupus erythematosus patients: functional and phenotypic characterization
Nancy Longo , A. Grammer
Arthritis Research & Therapy, 2003
View PDFchevron_right
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
Capucine Daridon
Arthritis Research & Therapy, 2014
View PDFchevron_right
Rheumatoid Factors Induce Signaling from B Cells, Leading to Epstein-Barr Virus and B-Cell Activation
Kazuya Iwabuchi
Journal of Virology, 2004
View PDFchevron_right
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael Cancro
Journal of Clinical Investigation, 2009
View PDFchevron_right
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
William Stohl
Arthritis & Rheumatism, 2008
View PDFchevron_right
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
Jorge Alcocer-Varela
Journal of Experimental Medicine, 1995
View PDFchevron_right
Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus
D. Gladman
The Journal of Immunology, 2008
View PDFchevron_right
Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes
Luis Caminal-Montero
Rheumatology (Oxford, England), 2014
View PDFchevron_right